Directory
>
Kurt Gunter Md Fascp
Kurt Gunter Md Fascp
SVP and Chief Medical Officer | Inozyme Pharma
Houston, Texas, United States
Kurt Gunter Md Fascp
Summary
Dr. Kurt Gunter is a distinguished medical professional with extensive experience in the fields of hematology, oncology, and regenerative medicine. He holds a B.S. with distinction from Stanford University and an M.D. from the University of Kansas School of Medicine, complemented by a fellowship at the US National Institutes of Health. As the SVP and Chief Medical Officer at Inozyme Pharma, he leads innovative research in rare diseases and enzyme technology. His career spans significant roles at the FDA, where he contributed to policy development in cellular and gene therapies, and multiple leadership positions in private biotech companies. Dr. Gunter is also actively involved in various scientific societies and has served as president of the International Society for Cell and Gene Therapy. His commitment to advancing medical science is evident through his participation in advisory roles and grant review committees. Beyond his professional accolades, he is recognized for his mentorship in the medical community, shaping the next generation of healthcare leaders.
Kurt Gunter Md Fascp
Work Experience
SVP and Chief Medical Officer at
Inozyme Pharma
June 2022 - Present
Member, Strategic Advisory Council at
International Society For Cell And Gene Therapy
January 2018 - Present
Chief Medical Officer for Cell Therapy at
Athenex
May 2021 - May 2022
Chief Medical Officer at
Kuur Therapeutics
March 2020 - May 2021
Chief Medical Officer at
Cell Medica
January 2013 - March 2020
President at
International Society For Cell And Gene Therapy
January 2012 - January 2014
VP Clinical Development at
Hospira
January 2012 - March 2013
Global Medical Director at
Hospira
January 2006 - January 2012
VP, Clinical and Medical Affairs/Goverment Relations at
ZymeQuest
January 2005 - January 2006
Senior VP, Clinical and Regulatory Affairs/Government Relations at
Bayfield Associates
January 2001 - January 2005
Vice President at
Transkaryotic Therapies Inc
January 1996 - January 2001
Director, Stem Cell Processing/Donor Center/Hematology at
Childrens National Medical Center
January 1993 - January 1996
Deputy Director, Division of Cellular and Gene Therapies at
FDA
January 1988 - January 1993
Kurt Gunter Md Fascp
Education
Johns hopkins school of medicine, Residency/Fellowship
Stanford University, Bachelor Of Science (Bs) With Distinction
US National Institutes of Helath, Fellowship
University of Kansas, Doctor Of Medicine (Md)
Frequently Asked Questions about Kurt Gunter Md Fascp
What is Kurt Gunter Md Fascp email address?
Kurt Gunter Md Fascp's primary email address is ***********@inozyme.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Kurt Gunter Md Fascp work for?
Kurt Gunter Md Fascp is a SVP and Chief Medical Officer at Inozyme Pharma, a company specializing in Commercial physical research.
Where Kurt Gunter Md Fascp graduated from?
Kurt Gunter Md Fascp holds a degree in Pathology/Transfusion Medicine from Johns hopkins school of medicine.
How can I directly contact Kurt Gunter Md Fascp?
To contact Kurt Gunter Md Fascp directly, you can use the email address ***********@inozyme.com. Complete contact information is available upon registration with Muraena.
Who is Kurt Gunter Md Fascp?
Dr. Kurt Gunter is a distinguished medical professional with extensive experience in the fields of hematology, oncology, and regenerative medicine. He holds a B.S. with distinction from Stanford University and an M.D. from the University of Kansas School of Medicine, complemented by a fellowship at the US National Institutes of Health. As the SVP and Chief Medical Officer at Inozyme Pharma, he leads innovative research in rare diseases and enzyme technology. His career spans significant roles at the FDA, where he contributed to policy development in cellular and gene therapies, and multiple leadership positions in private biotech companies. Dr. Gunter is also actively involved in various scientific societies and has served as president of the International Society for Cell and Gene Therapy. His commitment to advancing medical science is evident through his participation in advisory roles and grant review committees. Beyond his professional accolades, he is recognized for his mentorship in the medical community, shaping the next generation of healthcare leaders.
Kurt`s contact details
***********@inozyme.com
****@celltherapysociety.org
***********@hospira.com
Colleagues
Chief Financial Officer
Vice President Information Technology
SVP | Chief Technical Operations Officer
Vice President Worldwide Clinical Operations & Site Strategy
SVP & Chief People Officer
Vice President, Head of Program Management
Chief Executive Officer And Chairman
Vice President, Toxicology
Scientific Founder
Vice President, Regulatory Affairs, Medical Writing, and Pharmacovigilance